REGULATORY CONSIDERATIONS OF BIOSIMILARS AND CLINICAL DILEMA OF THEIR USE

REGULATORY CONSIDERATIONS OF BIOSIMILARS AND CLINICAL DILEMA OF THEIR USE

Biomedical products are complex molecules, produced by living cells. More accurately, they are molecules that are naturally produced in the human body, like hormones or growth factors, monoclonal antibodies, blood products, immunological medicinal products, sera and vaccines, allergens, and advanced...

Full description

Bibliographic Details
Main Authors: Sonja Genadieva Stavrik, Aleksandra Grozdanova, Katerina Ancevska Netkovska, Magdalena Genadieva Dimitrova, Gligor Dimitrov
Format: Article
Language:English
Published: Association of medical doctors Sanamed Novi Pazar 2017-04-01
Series:Sanamed
Subjects:
biosimilars
innovate product
monoclonal antibodies
regulatory
Online Access:http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/158/85

Internet

http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/158/85

Similar Items